Skip to content

MACawake of sevoflurane in women with sleep disorder

MACawake of sevoflurane in women with sleep disorder

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016022
Enrollment
Unknown
Registered
2018-05-07
Start date
2018-06-05
Completion date
Unknown
Last updated
2018-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep disorder

Interventions

Sponsors

First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Females aged 45-65 years, undergoing elective surgery using general anaesthesia with an ASA physical status classification of I or II.

Exclusion criteria

Exclusion criteria: Any neurological disease or having received central nervous systemactive drugs; a cardiac ejection fraction<40%; previous history of difficult intubation or anticipated difficult intubation; daily alcohol consumption; and obesity (defined as a body mass index .30 kg m–2). Those without informed consent were also excluded.

Design outcomes

Primary

MeasureTime frame
MACawake;

Secondary

MeasureTime frame
orexin-A;

Countries

China

Contacts

Public ContactYe ZHANG

The Second Affiliated Hospital of Anhui Medical University

zhangye_hassan@sina.com+86 0551 63869480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 28, 2026